June 2008 GWB Technology Column
Thursday, June 26th, 2008Trans1 Launches New Spine Product
TranS1 Inc., a publicly-traded Wilmington-based medical device company focuses on minimally invasive surgical approaches to treating degenerative disc disease in the lower lumbar region of the spine. The company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AxiaLIF 2L, a two level lumbar fusion system, in the United States. The AxiaLIF 2L is designed to treat degenerative disc disease at both the L5-S1 and L4-L5 lumbar discs through a single, one and a half inch incision.